Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.98 USD | -1.32% | -2.30% | -7.45% |
14/05 | Earnings Flash (OVID) OVID THERAPEUTICS Posts Q1 Revenue $148,000 | MT |
14/05 | Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.45% | 21Cr | |
+16.73% | 12TCr | |
+13.04% | 11TCr | |
-5.80% | 2.4TCr | |
+2.47% | 2.26TCr | |
-10.09% | 1.82TCr | |
-40.52% | 1.68TCr | |
-14.00% | 1.62TCr | |
+1.18% | 1.34TCr | |
+24.18% | 1.13TCr |
- Stock Market
- Equities
- OVID Stock
- News Ovid Therapeutics Inc.
- Transcript : Ovid Therapeutics Inc. Presents at RBC Capital Markets 2021 Global Healthcare Conference, May-19-2021 09